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Quantifying	  the	  interactions	  of	  bacteria	  with	  external	  ligands	  is	  fundamental	  to	  the	  
understanding	   of	   pathogenesis,	   antibiotic	   resistance,	   immune	   evasion,	   and	  
mechanism	   of	   antimicrobial	   action.	   Due	   to	   inherent	   cell-­‐to-­‐cell	   heterogeneity	   in	   a	  
microbial	   population,	   each	   bacterium	   interacts	   differently	   with	   its	   environment.	  
This	  large	  variability	  is	  washed	  out	  in	  bulk	  assays,	  and	  there	  is	  a	  need	  of	  techniques	  
that	  can	  quantify	  interactions	  of	  bacteria	  with	  ligands	  at	  the	  single	  bacterium	  level.	  
In	  this	  work,	  we	  present	  a	  label-­‐free	  and	  real-­‐time	  plasmonic	  imaging	  technique	  to	  
measure	  the	  binding	  kinetics	  of	  ligand	  interactions	  with	  single	  bacteria,	  and	  perform	  
statistical	   analysis	   of	   the	   heterogeneity.	   Using	   the	   technique,	   we	   have	   studied	  
interactions	   of	   antibodies	   with	   single	   Escherichia	   Coli	   O157:H7	   cells	   and	  
demonstrated	  a	  capability	  of	  determining	  the	  binding	  kinetic	  constants	  of	  single	  live	  
bacteria	  with	  ligands,	  and	  quantify	  heterogeneity	  in	  a	  microbial	  population.	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1. Introduction	  
Bacteria	   interact	  with	  environment	  through	  their	  surface	  constituents,	  such	  
as	   lipid	  bilayers,	  peptidoglycan	   layers,	   lipopolysaccharides	   (LPS),	  pilli,	   flagella	  and	  
outer	  membrane	   proteins.	   The	   surfaces	   of	   bacteria	   act	   as	   the	   first	   line	   of	   defense	  
against	   harmful	   external	   stimuli,	   including	   antibiotics(Delcour,	   2009)	   and	  
antimicrobial	   peptides,(Fantner	   et	   al.,	   2010;	   Sochacki	   et	   al.,	   2011)	   and	   also	   play	  
crucial	   roles	   in	   interacting	   with	   other	   surfaces,	   including	   host	   tissues(Van	   Houdt	  
and	  Michiels,	  2005)	  and	  medical	  plastics,(Lower	  et	  al.,	  2011)	  to	  help	  bacterial	  cells	  
attach	   and	   colonize.	   In	   order	   to	   survive	   in	   a	   changing	   environment,	   bacteria	  
replicate	  and	  evolve	  quickly,(Carnes	  et	  al.,	  2010;	  van	  der	  Mei	  and	  Busscher,	  2012)	  
leading	   to	   diversity	   of	   different	   bacteria	   species,	   and	   variability	   within	   the	   same	  
species.(van	   der	   Mei	   and	   Busscher,	   2012;	   Woude	   and	   Bäumler,	   2004)	   It	   is	   thus	  
important	  to	  study	  and	  quantify	  the	  interactions	  of	  bacteria	  with	  external	  ligands	  at	  
the	  single	  bacterium	  level.	  
The	  interactions	  of	  external	  ligands	  and	  bacteria	  have	  been	  studied	  using	  ex	  
situ	  and	  in	  situ	  approaches,	  such	  as	  fluorescence	  assay,(Cywes-­‐Bentley	  et	  al.,	  2013)	  
quartz	   crystal	  microbalance	   (QCM)(Shen	   et	   al.,	   2007),	   surface	   plasmon	   resonance	  
(SPR)(Medina	  et	  al.,	  1997;	  Subramanian	  et	  al.,	  2006),	  microcantilevers(Longo	  et	  al.,	  
2013)	  and	  atomic	  force	  microscope	  (AFM).(Fantner	  et	  al.,	  2010;	  Lower	  et	  al.,	  2011)	  
The	  ex	  situ	  approaches	  include	  the	  study	  of	  reconstituted	  artificial	  membranes(Früh	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et	   al.,	   2011;	   Hirst	   et	   al.,	   2013),	   membrane	   protein	   embedded	   liposomes(Liu	   and	  
Boyd,	  2013),	  and	  extracted	  surface	  constituents	  (e.g.,	  membrane	  proteins(Holden	  et	  
al.,	  2006)	  and	  sugars(Grant	  et	  al.,	  2008)	  from	  bacteria.	  Given	  the	  complexity	  of	  the	  
bacteria,	  in	  situ	  study	  of	  intact	  bacterial	  cells	  in	  their	  native	  environments	  are	  more	  
attractive.(Lee,	  2004)	  	  
	   Traditional	   studies	   of	   intact	   bacteria	   cells	   are	   largely	   based	  on	  bulk	   assays	  
and	  susceptibility	  testing	  assays,	  using	  techniques	  such	  as	  SPR(Chiang	  et	  al.,	  2009;	  
Medina	   et	   al.,	   1997;	   Subramanian	   et	   al.,	   2006)	   and	   disk-­‐diffusion(Jorgensen	   and	  
Ferraro,	  2009).	  The	  data	  generated	  with	  these	  bulk	  assays	  are	  averaged	  over	  many	  
bacteria,	   which	   wash	   out	   important	   variability	   or	   heterogeneity	   of	   different	  
bacterial	   cells.	  Various	   imaging	   techniques,	   such	  as	   fluorescence(Cywes-­‐Bentley	  et	  
al.,	  2013;	  Sochacki	  et	  al.,	  2011),	  AFM	  (Fantner	  et	  al.,	  2010;	  Lower	  et	  al.,	  2011)	  and	  
transmission	   electron	   microscopy	   (TEM)(Cywes-­‐Bentley	   et	   al.,	   2013),	   and	   non-­‐
imaging	  microfluidics	   techniques,	   such	   as	   flow	   cytometry(Tracy	   et	   al.,	   2010)	   and	  
micro	   electrophoresis(van	   der	  Mei	   and	  Busscher,	   2012),	   have	   been	   used	   to	   study	  
bacterial	   surfaces.	   These	   techniques	   have	   contributed	   to	   the	   understanding	   of	  
bacteria,	   but	   each	   has	   disadvantages.	   For	   example,	   the	   fluorescence	   method	  
requires	   labeling,	  which	   limits	   its	   application	   to	  only	   certain	  probe	  molecules	  and	  
cultivable	  strains,	  and	  gram	  negative	  bacteria	  with	  sugars	  cannot	  be	  easily	   labeled	  
by	   engineering	   cells.(Chang	   and	   Bertozzi,	   2012)	   In	   addition,	   the	   fluorescence	  
method	   is	  an	  end-­‐point	  assay,	  which	   is	  not	   suitable	   for	  quantifying	   the	  kinetics	  of	  
molecular	  binding	   to	  bacteria.	  TEM	  requires	  extensive	  sample	  preparations	  and	   is	  
unsuitable	   for	   live	   cell	   analysis	   in	  aqueous	   solutions.	  AFM	  can	  operate	   in	  aqueous	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solutions,	  but	   it	   is	  usually	   too	   slow	   to	   follow	   fast	  binding	  of	   ligands	  with	  bacteria,	  
and	   the	   scanning	   AFM	   probe	  may	   perturb	   the	   binding	   process.	   In	   this	   study,	   we	  
present	  a	  plasmonic	  imaging	  technique(Huang	  et	  al.,	  2007;	  Wang	  et	  al.,	  2010,	  2012)	  
(Fig.	  1a)	  to	  study	  and	  quantify	  the	  interactions	  of	  a	  single	  E.	  Coli	  O157:H7	  cell	  with	  
an	  antibody,	  and	  perform	  statistical	  analysis	  of	  the	  bacterial	  heterogeneity.	  
	   E.	  Coli	  O157:H7	  is	  a	  highly	  virulent	  food	  borne	  pathogen	  that	  causes	  diseases,	  
such	  as	  diarrhea,	  hemorrhagic	  colitis	  and	  hemolytic	  uremic	  syndrome.(Besser	  et	  al.,	  
1999)	  Many	  groups	  have	  tried	  detecting	  this	  pathogen	  by	  several	  culture	  assays	  as	  
well	  biosensing	  approaches.	  	  Several	  groups	  have	  used	  conventional	  SPR	  to	  detect	  E.	  
Coli	   O157:H7	   by	   direct	   detection	   of	   bacterial	   cells	   binding	   to	   surface(Tawil	   et	   al.,	  
2012;	   Torun	   et	   al.,	   2012)	   ,	   indirect	   detection	   of	   surface	   immobilized	   cells	   using	  
complementary	  probes(Medina	  et	  al.,	  1997;	  Subramanian	  et	  al.,	  2006)	  or	  coupling	  
SPR	   with	   other	   techniques.(Zordan	   et	   al.,	   2009)	   In	   this	   study,	   we	   focus	   on	   the	  
binding	  kinetics	  of	  goat	  anti-­‐E	  Coli	  O157:H7	  IgG	  polyclonal	  antibody(Ab157)(Medina	  
et	  al.,	  1997;	  Subramanian	  et	  al.,	  2006)	  onto	  single	  E.	  Coli	  O157:H7	  cells.	  Commercial	  
humanized	   antibodies	   are	   increasingly	   used	   as	   an	   alternate	   therapy	   for	   immune	  
clearance	   of	   pathogens,(Casadevall	   et	   al.,	   2004;	   Cywes-­‐Bentley	   et	   al.,	   2013)	   hence	  
the	   study	   of	   antibody	   binding	   kinetics	   with	   single	   bacterial	   cells	   is	   important	   to	  




2. Materials	  and	  Methods	  
Materials	   -­‐	   Lyophilized	   Bacterial	   pellets	   of	   E.	   Coli	   O157:H7	   (ATCC43888)	   were	  
purchased	  from	  Fisher	  Scientific.	  Affinity	  purified	  goat	  anti-­‐E.	  coli	  O157:H7	  IgG	  and	  
anti-­‐E.	   coli	   O145:H7	   polyclonal	   antibodies	   were	   purchased	   from	   Kirkegaard	   and	  
Perry	   Laboratory	   Inc.	   (Gaithersburg,	   MD)	   and	   suspended	   in	   1ml	   PBS	   (1x).	  
Secondary	  antibody	  Alexa	  Fluor	  555	  rabbit	  anti-­‐goat	  IgG	  (H+L)	  was	  purchased	  from	  
Life	   Technologies	   (Carsbad,	   CA).	   (1-­‐Mercapto-­‐11-­‐undecyl)	   hexa(ethylene	   glycol)	  
(PEG)	   and	  Carboxyl-­‐terminated	  hexa(ethylene	   glycol)	   undecane	   thiol	   (PEG-­‐COOH)	  
was	   purchased	   from	   Nanoscience	   Instruments	   (Phoenix).	   Other	   reagents	   were	  
purchased	  from	  Sigma-­‐Aldrich.	  
	  
Bacteria	   Purification	   -­‐	  The	   lyophilized	   bacteria	  was	   suspended	   in	   1ml	   PBS	   (1x)	  
and	  cleaned	  by	  centrifugation	  at	  the	  speed	  of	  50g	  for	  1	  minute	  to	  remove	  charcoal	  
and	   collecting	   the	   supernatant	   containing	  bacteria.	  The	   supernatant	  was	   collected	  
and	  washed	  further	  by	  pelleting	  bacteria	  in	  the	  centrifuge	  at	  the	  speed	  of	  2000g	  for	  
15	  minutes.	  	  The	  pelleted	  bacteria	  was	  suspended	  in	  1ml	  PBS	  and	  mixed	  thoroughly.	  
Further,	  the	  above	  washing	  step	  was	  repeated	  three	  times.	  The	  final	  1ml	  of	  bacteria	  
in	  PBS	  solution,	  after	  3	  rounds	  of	  purification,	  was	  saved	  in	  small	  aliquots	  of	  20	  µl	  
and	  frozen	  at	  -­‐80	  °C.	  
	  
Surface	  Functionalization	  –	  Clean	  BK7	  glass	  cover	  slips	  were	  coated	  with	  1.5	  nm	  
chromium	   and	   47	   nm	   gold	   to	   prepare	   SPR	   chips.	   The	   chips	   were	   cleaned	   with	  
deionized	  water	   and	  ethanol	  multiple	   times	   and	  blown	  dry	  with	  nitrogen	  gas	   and	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then	   cleaned	   by	   hydrogen	   flame.	   The	   cleaned	   chips	   were	   submerged	   in	   1	   mM	  
PEG/PEG-­‐COOH	  ethanol	  solution	  and	  left	  overnight	  in	  dark	  for	  24	  hrs.	  The	  overnight	  
incubated	  chips	  were	  taken	  out	  and	  cleaned	  with	  deionized	  water,	  ethanol	  solution	  
multiple	   times	   and	   blown	   dry	   with	   nitrogen	   gas.	   PEG/PEG-­‐COOH	   self-­‐assembled	  
monolayer	  (SAM)	  was	  deposited	  on	  each	  chip	  with	  this	  protocol.	  
Next,	   the	   SAM	   coated	   chip	   was	   activated	   with	   0.5	   ml	   of	   freshly	   prepared	  
mixture	  (1:1)	  of	  0.1	  M	  NHS	  and	  0.4M	  EDC	  to	  produce	  NHS	  ester	  receptors	  capable	  of	  
binding	  with	  amino	  group	  of	   antibodies	  via	   an	  amide	  bond.	  The	   chip	  was	   cleaned	  
with	   deionized	   water	   and	   blown	   dry	   with	   nitrogen	   gas.	   Polyclonal	   anti-­‐E.Coli	  
O157:H7	   antibody	   suspended	   in	   20mM	   sodium	   acetate	   (NaOAc)	   pH	   5.5	   at	   the	  
concentration	   (30ug/ml)	   optimized	   for	   maximum	   bacteria	   immobilization	   was	  
immediately	  applied	  to	  NHS/EDC	  activated	  surfaces	  above	  and	  kept	  for	  about	  60-­‐90	  
mins.(Subramanian	  et	  al.,	  2006)	  The	  chip	  was	  again	  cleaned	  by	  deionized	  water	  and	  
blown	  dry	  with	  nitrogen	  gas.	  This	  antibodies	  conjugated	  sensor	  chips	  are	  ready	  for	  
bacteria	  capture	  on	  SPRM	  setup	  later.	  	  
	  
Plasmonic	  imaging	  and	  Flow	  Setup	  -­‐	  The	  plasmonic	  imaging	  setup	  is	  based	  on	  the	  
Kretschmann	  configuration	  with	  a	  high	  numerical	  aperture	  objective	  (NA	  1.49)	  and	  
an	  inverted	  microscope	  (Olympus	  IX81)	  (Fig.	  1).	  The	  sensor	  chip	  was	  placed	  on	  the	  
objective	   lens	   with	   refractive	   index	   matching	   immersion	   oil.	   A	   680nm	   super	  
luminescence	  diode	  (Qphotonics,	  Ann	  Arbor,	  MI)	  was	  used	  to	  excite	  the	  SPR	  images	  
and	   a	   CCD	   camera	   (Pike-­‐032B,	   Allied	   Vision	   Technologies,	   Newbuyport,	  MA)	  was	  
used	  to	  record	  SPRM	  images.	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A	  FlexiPerm	  sample	  well	  was	  mounted	  on	  top	  of	  the	  antibody	  functionalized	  
gold	   chip	   and	   filled	   with	   PBS	   (1x)	   buffer.	   The	   assembled	   gold	   chip	   was	   then	  
mounted	  on	  top	  of	  the	  plasmonic	  imaging	  setup.	  The	  incident	  angle	  of	  the	  light	  beam	  
was	   adjusted	   to	   the	   surface	   plasmon	   resonance	   angle,	   showing	   minimal	   image	  
intensity.	  	  
Sample	  delivery	  was	  based	  on	  a	  multichannel	  gravity	  based	  drug	  perfusion	  
system,	  which	  flew	  sample	  solutions	  over	  the	  immobilized	  bacterial	  cells.	  The	  flow	  
rate	  was	  330	  µl/min	  and	  the	  transition	  time	  between	  different	  flow	  solutions	  was	  in	  
the	  range	  of	  1-­‐2	  seconds.	  	  
	  
Bacteria	  Immobilization	  –	  An	  aliquot	  of	  frozen	  purified	  bacteria	  was	  thawed	  for	  2	  
minutes,	   and	   then	   20	   ul	   of	   bacteria	   were	   added	   to	   the	   sensor	   chip.	   The	   bacteria	  
started	  to	  attach	  and	  immobilize	  onto	  the	  sensor	  surface	  via	  antibody	  binding.	  After	  
about	  15-­‐20	  minutes	  of	  incubation,	  sufficient	  amount	  of	  bacteria	  were	  attached	  onto	  
the	   gold	   chip.	   1x	   PBS	   buffer	   was	   flowed	   over	   the	   chip	   to	   wash	   out	   unattached	  
bacteria	  from	  the	  solution,	  then	  5	  mg/mL	  BSA	  were	  added	  to	  the	  chip	  and	  incubated	  
for	  1	  hour	   to	   completely	  block	   the	   surface	  and	  prevent	  non-­‐specific	   adsorption	  of	  
antibody.	  
	  
Immunofluorescence	  microscopy	  –	  Following	  kinetics	  of	  Ab157	  binding	  to	  E.	  Coli	  
O157:H7	   cells,	   fluorescence	   labeled	   secondary	   antibody	   at	   a	   concentration	   of	   10	  




Image	  Collection	  and	  Processing	  –	  All	  plasmonic	  imaging	  videos	  were	  collected	  at	  
3.3	  fps	  at	  a	  pixel	  resolution	  of	  640x480.	  We	  chose	  an	  appropriate	  exposure	  time	  to	  
maximize	   image	   intensity	   at	   the	   same	   time	   avoiding	   over	   exposure.	   Images	  were	  
subtracted	   from	   the	   first	   recorded	   image	   to	   remove	   background	   noises	   and	  
interference	  patterns.	  Further,	   images	  were	  plotted	   in	  2D	   frequency	  domain	  using	  
Fast	  Fourier	  Transform	  (FFT)	  conversion,	  and	  cleaned	  up	  with	  a	  spatial	  band	  pass	  
filter.	   The	   cleaned	   images	   were	   converted	   back	   from	   frequency	   domain	   using	  
inverse	  FFT.	  For	  better	  visualization,	  images	  were	  converted	  to	  scaled	  color	  images.	  
	  
Data	   analyses	   from	   Images	   –	   As	   mentioned	   in	   text,	   the	   plasmonic	   imaging	  
intensity	  in	  each	  of	  the	  selected	  regions,	  including	  regions	  of	  the	  bacteria	  and	  bare	  
gold	   chip	   regions,	   was	   analyzed	   with	   a	   MATLAB	   program.	   The	   plasmonic	   image	  
intensity	   from	  each	  bacterium	  was	   reference	   corrected	  with	   the	   background	  bare	  
gold	   regions	   to	  analyze	   the	  binding	  kinetics.	  The	  binding	  kinetics	  was	  determined	  
with	  the	  first	  order	  kinetic	  equation,	  and	  ka,	  kd	  and	  KD	  (=ka/kd)	  were	  obtained	  from	  








3.	  Results	  and	  Discussion	  
E.	  Coli	  O157:H7	  bacteria	  were	  immobilized	  on	  the	  sensor	  chip	  using	  an	  anti-­‐
EColi	  O157	   (antibody	  Ab157),	  which	  were	   imaged	  with	  a	  plasmonic	   imaging	  setup	  
(Fig.	  1a)	  described	  in	  detail	  elsewhere.(Huang	  et	  al.,	  2007;	  Shan	  et	  al.,	  2012;	  Wang	  et	  
al.,	  2010,	  2012,	  2011)	  Briefly,	  the	  setup	  is	  based	  on	  an	  inverted	  optical	  microscope	  
(Olympus	  IX81)	  with	  high	  numerical	  aperture	  oil	  immersion	  objectives	  (N.A.=1.49).	  
Light	   from	   a	   super-­‐luminescence	   diode	   (Qphotonics,	   Ann	   Arbor,	   MI)	   with	  
wavelength	   of	   680	   nm	   is	   directed	   onto	   the	   sensor	   chip,	   made	   of	   glass	   coverslip	  
coated	  with	   a	  47	  nm	   thick	   gold	   film.	  The	   incident	   angle	   of	   light	   is	   tuned	   to	   excite	  
surface	  plasmons,	  and	  the	  reflected	  light	  is	  imaged	  with	  the	  same	  objective	  together	  
with	  other	  components,	  including	  a	  CCD	  imager.	  
The	  individual	  bacteria	  were	  imaged	  as	  distinct	  V-­‐shaped	  patterns	  (Fig.	  1c),	  
which	  match	  well	  with	  the	  positions	  of	  the	  bacteria	  in	  the	  Bright-­‐field	  optical	  image	  
(Fig.	  1b).	  These	  V-­‐shaped	  patterns	  are	  caused	  by	  the	  scattering	  of	  surface	  plasmonic	  
waves	  by	   the	  bacteria	   immobilized	  on	   the	  surface.(Wang	  et	  al.,	  2010)	  The	  distinct	  
patterns	   in	   the	   plasmonic	   image	   are	   helpful	   to	   distinguish	   bacterial	   cells	   from	  
interference	   patterns	   originated	   from	   the	   optical	   setup,	   and	   other	   spatial	  














Fig.	  1a)	  Schematic	  of	  the	  plasmonic	  imaging	  setup	  using	  a	  	  high	  numerical	  objective	  and	  the	  
immobilization	  of	  bacterial	  cells	  on	   top	  of	  gold	  chip	  by	  covalently	  attached	  antibodies.	   	  b)	  
Bright-­‐field	  optical	  image	  of	  immobilized	  bacteria.	  c)	  Plasmonic	  image	  of	  bacteria	  shown	  as	  
V-­‐shaped	   diffraction	   patterns	   at	   positions	   of	   bacteria	   on	   bright	   field	   image.	   d)	  Magnified	  







plasmonic	   image	  of	   a	   single	  bacterium	  showing	   clearly	   the	  V-­‐shape	  diffraction	  pattern.	   e)	  
3D	  histogram	  of	  the	  bacteria	  in	  Fig.	  1d.	  f)	  Profile	  of	  the	  V-­‐shaped	  pattern	  along	  the	  basin	  of	  
V	   in	  Fig.	  4d.	  g)	  Profile	  of	   the	  V-­‐shaped	  pattern	  along	  the	  middle	  axis	   in	  Fig.	  4d.	   	  Scale	  bar:	  
2µm	  	  
Figs.	  1d	  and	  e	  show	  more	  clearly	  one	  of	  the	  V-­‐shaped	  patterns,	  and	  also	  reveal	  that	  
the	   region	   of	   maximum	   intensity	   in	   each	   V-­‐shaped	   pattern	   overlays	   one	  
immobilized	   bacterial	   cell.	   The	   intensity	   profile	   along	   the	   basin	   of	   the	   V	   shaped	  
diffraction	  pattern	  (X-­‐direction)	  of	  bacterial	  cells	  show	  a	  full-­‐width	  at	  half	  maximum	  
(FWHM)	  of	  about	  0.5	  µm	  (Fig.	  1f).	  This	  FWHM	  is	  due	  to	  the	  optical	  diffraction	  limit	  
of	   our	   setup.(Wang	   et	   al.,	   2010)	   The	   intensity	   profile	   along	   the	   plasmonic	   wave	  
propagation	  direction	  (Y-­‐direction)	  reveals	  that	  the	  intensity	  decays	  with	  a	  FWHM	  
of	   about	   ~4	  µm	   (Figure	   1g).	   The	   intensity	   decay	   is	   due	   to	   the	   finite	   propagation	  
length	  of	  surface	  plasmonic	  waves,	  which	  depends	  on	  the	  type	  of	  the	  metal	  film,	  and	  
the	  wavelength	   of	   incident	   light(Wang	   et	   al.,	   2010).	  We	   observe	   similar	   V-­‐shaped	  
patterns	   for	   all	   immobilized	  bacterial	   cells	  with	  no	  major	  differences	   in	   the	  decay	  
length	  and	  FWHM	  for	  different	  cells.	  
Using	   the	  plasmonic	   imaging	   setup,	  we	  next	   imaged	   the	  binding	  process	  of	  
Ab157	   antibody	   to	   the	   E.	   Coli	   O157:H7	   cells	   immobilized	   on	   the	   surface.	   Fig.	   2a	  
shows	  a	  bright-­‐field	  image	  of	  4	  immobilized	  bacterial	  cells.	  We	  started	  the	  binding	  
study	  by	  initially	  flowing	  1xPBS	  at	  330	  µl/min	  continuously	  over	  the	  bacterial	  cells	  
for	   about	   2	   minutes.	   We	   then	   switched	   the	   flow	   to	   1xPBS	   containing	   10	   µg/mL	  
Ab157	  to	  study	  the	  association	  of	  the	  antibody	  to	  the	  individual	  bacterial	  cells.	  After	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3	  minutes,	  we	  switched	  the	   flow	  back	  to	  1xPBS	   in	  order	   to	   follow	  the	  dissociation	  
process.	  	  
Since	   we	   are	   interested	   in	   the	   association	   and	   dissociation	   processes	   of	  
antibody	   onto	   the	   bacteria,	   time-­‐differential	   images	  were	   obtained	   by	   subtracting	  
the	  first	  frame	  from	  the	  subsequent	  frames	  to	  show	  changes	  in	  the	  image	  over	  time.	  
Fig.	   2b1	   is	   a	   time-­‐differential	   image	   captured	   before	   the	   introduction	   of	   solution	  
containing	  antibody,	  which	  shows	  weak	  contrast	  of	  the	  bacteria.	  If	  the	  bacteria	  were	  
static,	   then	   there	   should	   be	   no	   contrast	   in	   the	   time-­‐differential	   image	   before	  
antibody	  binding	  taking	  place.	  The	  observation	  of	  the	  small	  contrast	  is	  due	  to	  micro-­‐
motions	  of	  the	  live	  bacterial	  cells.	  We	  will	  return	  to	  this	  later.	  	  
Upon	  exposure	  to	  the	  PBS	  containing	  the	  antibody,	  binding	  of	  the	  antibody	  to	  
the	  bacteria,	  primarily	  via	  the	  O-­‐antigen(Park	  et	  al.,	  1998)	  on	  the	  outer	  membrane	  
surfaces	  of	   the	  bacteria,	   takes	  place,	  which	   is	  revealed	  as	  an	   increase	   in	   the	   image	  
contrast	  of	   the	   individual	  bacterial	  cells.	  Figs.	  2b2-­‐4	  show	  several	   time-­‐differential	  
plasmonic	  images	  of	  the	  association	  process	  from	  which	  detailed	  information	  of	  the	  
association	   process	   can	   be	   obtained.	   For	   example,	   the	   images	   show	   the	   contrast	  
increases	   for	   different	   cells	   are	   different,	   demonstrating	   the	   cell-­‐to-­‐cell	  
heterogeneity	   that	   is	   washed	   out	   in	   the	   bulk	   assay.	   The	   images	   also	   show	   the	  
increase	  in	  the	  intensity	  in	  the	  regions	  between	  the	  bacterial	  cells,	  which,	  as	  we	  will	  
discuss	  later,	  is	  mainly	  due	  to	  the	  increase	  in	  the	  bulk	  refractive	  index	  as	  we	  switch	  
the	  solution.	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Snapshots	  of	  the	  time-­‐differential	  plasmonic	  images	  during	  the	  dissociation	  process	  
are	   shown	   in	   Figs.	   2b5-­‐7,	   which	   were	   captured	   after	   switching	   the	   antibody-­‐
containing	  solution	  back	  to	  PBS.	  During	  the	  dissociation	  phase,	  the	  image	  intensity	  
of	  each	  bacterial	  cell	  decreases	  at	  a	  slow	  rate	  compared	  to	  the	  association	  process,	  
which	   is	   expected	   as	   the	   antibodies	   dissociate	   from	   the	   bacterial	   cell.	   Like	   the	  
association	  process,	  the	  dissociation	  also	  varies	  across	  different	  cells.	  Note	  also	  that	  
the	   image	   intensity	   in	   the	   regions	   without	   bacteria	   returns	   to	   the	   baseline	   level	  
quickly,	  which	  further	  supports	  the	  interpretation	  of	  bulk	  refractive	  index	  change	  as	  










Fig.	  2	  a)	  Bright-­‐field	  optical	  image	  of	  immobilized	  E.	  Coli	  O157:H7	  cells.	  The	  region	  chosen	  to	  
analyze	  the	  plasmonic	  image	  intensity	  of	  each	  bacterium	  is	  marked	  as	  a	  colored	  box	  in	  the	  
a	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  b1	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  b2	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  b3	  
 
b4	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  b5	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  b6	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  b7	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bright-­‐field	   image.	   Also	   shown	   is	   the	   background	   control	   region	   as	   a	   green	   box	   near	   the	  
center	  of	  the	  image.	  b)	  Time-­‐differential	  plasmonic	  images	  captured	  during	  different	  stages	  
of	   association	   (b1-­‐b4)	   and	  dissociation	   (b4-­‐b7)	  processes.	  A	   complete	  plasmonic	   video	  of	  
the	  binding	  kinetics	  is	  given	  in	  the	  supporting	  information.	  Scale	  bar:	  2µm.	  
	  
The	   image	   intensity	   vs.	   time	   profiles	   obtained	   from	   the	   recorded	   image	  
sequence	   provides	   detailed	   kinetic	   information	   of	   the	   antibody	   binding	   to	   the	  
bacterial	  cells	  (Fig.	  3).	  This	  type	  of	  plots	  has	  been	  widely	  referred	  to	  as	  sensorgrams,	  
but	   Fig.	   3	   represents	   the	   first	   sensorgrams	   on	   single	   bacterial	   cells.	   The	  
sensorgrams	  are	  “noisy”,	  which	  is	  mainly	  due	  to	  micromotions	  of	  the	  bacteria.	  The	  
bacterial	  cells	  in	  the	  present	  work	  were	  alive	  and	  attached	  to	  the	  sensor	  surface	  via	  
relatively	   weak	   non-­‐covalent	   bonds,	   so	   we	   observed	   frequent	   movement	   of	   the	  
bacterial	  cells	  in	  the	  plasmonic	  images.	  Despite	  the	  micro-­‐motions,	  the	  sensorgrams	  
can	  be	  fit	  with	  the	  first	  order	  kinetics	  model,	  from	  which	  kinetic	  constants,	  including	  
ka,	   kd	   and	  KD,	   for	   each	   of	   the	   bacteria	   cells	   are	   obtained	   (see	  Table	   1).	   Fig.	   3	   also	  
plots	   the	   image	   intensity	   vs.	   time	   profile	   of	   a	   region	   between	   the	   bacteria	   cells,	  
which	  shows	  only	  a	  bulk	   index	  change	  with	  no	  binding	  kinetics	  curve	  as	  observed	  
over	   bacterial	   cells.	   This	   observation	   indicates	   that	   non-­‐specific	   binding	   of	   the	  






Fig.	  3	  Sensorgrams	  of	  single	  bacterial	  cells	  obtained	  by	  plotting	  the	  image	  intensity	  vs.	  time.	  
Smooth	   solid	   lines	   are	   fits	   to	   the	   first	   order	   kinetics	   for	   different	   cells,	   allowing	   the	  
determination	  of	  kinetic	  constants,	  ka,	  kd	  and	  KD	  for	  each	  of	  the	  bacteria	  cells.	  The	  green	  line	  
plots	   the	   sensorgram	   of	   a	   region	   without	   bacteria	   cells,	   showing	   a	   sudden	   increase	   and	  
decrease	  as	  the	  flow	  is	  switched	  from	  PBS	  buffer	  solution	  to	  sample	  solution,	  and	  then	  back	  
to	  PBS	  buffer,	  respectively.	  




-­‐1	  s-­‐1	  )	  
Dissociation	  rate	  	  (kd)	  
(s-­‐1	  )	  




Bacteria	  1	   5.1	  x	  104	   6.9	  x	  10-­‐4	   1.3	  x	  10-­‐8	   97.5	  
Bacteria	  2	   1.3	  x	  105	   5.1	  x	  10-­‐5	   4.0	  x	  10-­‐10	   50.8	  
Bacteria	  3	   5.1	  x	  104	   2.1	  x	  10-­‐4	   4.1	  x	  10-­‐9	   67.0	  




To	   further	   validate	   the	   plasmonic	   imaging	   of	   the	   antibody	   binding	   to	  
bacterial	   cells,	   we	   used	   AlexaFlor555	   labeled	   secondary	   antibody	   to	   bind	   to	   the	  
attached	  primary	  antibody.	  Fig.	  4	  shows	  the	  conventional	  bright	  field	  optical,	  time-­‐
differential	   plasmonic	   and	   fluorescence	   images	   of	   a	   sensor	   surface	   covered	   with	  
multiple	  bacteria	  cells.	  The	  fluorescence	   image	  (Fig.	  4c)	  confirms	  that	  the	   increase	  
in	  the	  plasmonic	  image	  intensity	  is	  due	  to	  the	  binding	  of	  the	  primary	  antibody	  to	  the	  
bacterial	   cells.	   As	   an	   additional	   validation	   experiment,	  we	   used	   a	   goat	  anti-­‐E.	   coli	  
O145	  IgG	  polyclonal	  antibody	  (Ab145)	  as	  a	  negative	  control.	  The	  exposure	  of	  E.	  Coli	  
cells	   to	   Ab145	   did	   not	   change	   the	   plasmonic	   image	   intensity	   (Supplemental	  
Information	  –	  Fig.	  1),	  indicating	  that	  the	  binding	  kinetics	  of	  Ab157	  with	  E.	  Coli	  cells	  
were	  specific.	  
The	   results	  discussed	  above	  demonstrate	   a	  new	  capability	   for	   studying	   the	  
binding	   kinetics	   of	   single	   bacteria.	   Compared	   to	   the	   conventional	   SPR	   approach	  
which	   studies	   a	   layer	   of	   many	   bacterial	   cells	   immobilized	   on	   a	   sensor	  
surface,(Medina	  et	  al.,	  1997;	  Subramanian	  et	  al.,	  2006)	   the	   single	  bacteria	  binding	  
kinetics	  analysis	  capability	  can	  discriminate	  non-­‐specific	  binding	  taking	  place	  on	  the	  
regions	  of	   the	  sensor	  surface	  without	  bacteria	  cells.	  More	   importantly,	   it	  opens	  up	  
the	  possibility	   of	   detecting	   individual	  microbes	   in	  mixed	   communities,	   biofilms	   as	  
well	  as	  microbe-­‐infected	  patient	  samples.	  We	  demonstrate	  below	  kinetics	  analysis	  


















Fig	   4.	   a)	   Bright-­‐field	   optical	   image	   of	   bacteria	   immobilized	   on	   a	   gold	   chip.	   b)	   Time-­‐
differential	   plasmonic	   image	   showing	   V-­‐shape	   diffraction	   patterns	   corresponding	   to	   the	  
individual	  bacterial	  cells	  in	  Fig.	  4a.	  c)	  Fluorescence	  image	  after	  adding	  secondary	  antibody	  





	   Figs.	  5a	  and	  5b	  show	  the	  distributions	  of	  ka	  and	  kd	  values,	  respectively.	  The	  
data	   were	   obtained	   by	   fitting	   the	   sensorgram	   of	   each	   bacterial	   cell	   (33	   bacteria	  
cells)	  with	  the	  first	  order	  binding	  kinetics	  model.	  Although	  the	  number	  of	  bacterial	  
cells	  was	  limited,	  the	  data	  shows	  2	  orders	  of	  magnitude	  variability	  in	  ka	  and	  kd.	  KD	  
was	  obtained	  from	  the	  ka	  and	  kd	  values	  with	  the	  relation,	  KD=kd	  /ka	  (Fig.	  5c).	  Unlike	  
the	  distributions	  of	  ka	  and	  kd,	  the	  distribution	  of	  KD	  has	  a	  center,	  which	  is	  near	  3.9	  
nM.	  This	  KD	  value	  is	  close	  to	  the	  previously	  reported	  values	  in	  literature.(Medina	  et	  
al.,	   1997)	   However,	   the	   presence	   of	   4	   orders	   of	   magnitude	   in	   KD	   conveys	   the	  
heterogeneity	  in	  how	  an	  antibody	  might	  interact	  with	  individual	  cells.	  	  








Fig.	  5	  Distributions	  of	  association	  rate,	  ka	  (a),	  dissociation	  rate,	  kd	  (b),	  dissociation	  constant,	  
KD,	   (c)	   observed	   on	   various	   bacteria.	   The	   large	   variability	   in	   the	   observed	   kinetics	  
conveying	  cell-­‐cell	  heterogeneity	  in	  Ab157	  interacting	  with	  bacterial	  cells.	  
	  
We	  also	  obtained	  distribution	  (Supplemental	  Fig.	  2)	  of	  the	  plasmonic	  image	  
intensity	  measured	  at	  the	  end	  of	  association	  phase	  from	  various	  bacterial	  cells.	  Since	  
the	   plasmonic	   intensity	   is	   proportional	   to	   the	  mass	   density	   change	   of	   the	   sensor	  
a	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  b	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  c	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surface,	  the	  data	  reflects	  the	  distribution	  in	  the	  expression	  levels	  of	  O-­‐antigen	  on	  the	  
outer	  membranes	  of	  the	  bacterial	  cells.	  We	  performed	  statistical	  analysis	  and	  found	  
no	   obvious	   correlations	   between	   the	  measured	  O-­‐antigen	   expression	   levels,	   ka,	   kd	  
and	   KD	   and	   the	   physical	   parameters,	   including	   length	   and	   size,	   of	   the	   bacteria	  
(Supplemental	  Information	  –	  Table	  1).	  	  
We	  believe	   that	   the	   reason	   for	   the	  observed	  cell-­‐to-­‐cell	  variability	   is	   the	  O-­‐
antigen	  on	  the	  surfaces	  of	  the	  bacteria,(Park	  et	  al.,	  1998)	  which	  is	  the	  target	  for	  the	  
antibody.	   Studies	   have	   shown	   large	   variations	   in	   the	   chain	   length	   of	   O-­‐antigen,	  
which	   give	   E.	   Coli	   distinct	   surface	   morphologies	   (smooth,	   semi-­‐rough	   and	  
rough).(Reyes	  et	   al.,	   2012)	  This	  variation	   in	   chain	   length	  exists	  owing	   to	  Wzz	  and	  
Wzy	   proteins,	   which	   are	   responsible	   for	   modulating	   the	   O-­‐antigen	   chain	   lengths.	  
Wzz	   assembles	   the	   O-­‐antigen	   around	   a	   specific	   modal	   length	   whereas	   Wzy	  
assembles	  O-­‐antigen	   to	  a	  stochastic	   length.(Whitfield	  and	  Larue,	  2008;	  Woodward	  
et	   al.,	   2010)	   These	   variations	   in	   O-­‐antigen	   may	   be	   the	   primary	   reason	   for	   the	  
observed	  cell-­‐to-­‐cell	  variability	  in	  the	  antibody	  binding	  kinetics.	  
The	  wide	  distributions	   in	   kinetic	   constants	   indicate	   the	  natural	   phenotypic	  
diversity	   in	  a	  bacterial	  population.	  Capturing	  this	  diversity	   is	   important,	  especially	  
because	   microbial	   sub-­‐populations	   with	   variable	   phenotypic	   characteristics	   are	  
known	   to	   play	   an	   important	   role	   in	   microbial	   evolution	   and	   antibiotic	  
resistance.(Lidstrom	  and	  Konopka,	  2010)	  The	  traditional	  bulk	  assays	  that	  measure	  
average	  KD	  of	  a	  large	  number	  of	  bacteria	  cells	  could	  be	  misleading,	  especially	  when	  a	  
species	   evolves	   and	   sub-­‐populations	   emerge.	   In	   contrast,	   the	   present	   plasmonic	  
imaging	   method	   can	   provide	   quantitative	   analysis	   of	   ligand	   interactions	   with	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individual	  live	  bacteria,	  which	  represents	  an	  unprecedented	  capability	  for	  studying	  
the	   role	   of	   physiological	   heterogeneity	   in	   microbial	   population	   behaviors	   and	  




We	   have	   described	   a	   plasmonic	   imaging	   method	   for	   studying	   the	   interaction	  
kinetics	   between	  biomolecules	   and	   individual	   bacterial	   cells.	   The	  method	   is	   label-­‐
free,	  quantitative	  and	  in	  real	  time.	  Using	  the	  method,	  we	  have	  measured	  the	  kinetics	  
of	  an	  antibody	  binding	  to	  single	  E.	  Coli	  O157:H7	  bacterial	  cells.	  The	  mean	  values	  of	  
the	  measured	  kinetic	  constants	  (e.g.,	  KD)	  are	  consistent	  with	  the	  reported	  literature	  
values	  obtained	  from	  bulk	  assays.	  However,	  the	  present	  method	  revealed	  large	  cell-­‐
to-­‐cell	  variations	  in	  binding	  kinetics	  with	  kinetic	  constants	  distributed	  over	  several	  
orders	  of	  magnitude.	  These	   results	  are	  direct	  evidence	   that	   large	  heterogeneity	   in	  
the	  binding	  capability	  of	  bacteria	  with	  external	  ligands	  naturally	  exists	  in	  a	  bacterial	  
population.	  Such	  heterogeneity	  has	  been	  hypothesized	  as	  an	  important	  mechanism	  
for	  evolution	  and	  fitness	   in	  microbes.	  We	  anticipate	  that	  this	  method	  will	   improve	  
the	  understanding	  of	  bacterial	  behaviors,	  such	  as	  pathogenesis	  and	  immune	  escape	  
of	   virulent	   microbes,	   action	   and	   efficacy	   of	   antimicrobial	   peptides	   in	   acting	   on	   a	  
microbial	   population	   and	   binding	   affinities	   of	   humanized	   antibodies	   against	  












Supporting	  Information	  Available	  
Results	   of	   negative	   control	   experiment,	   distribution	   of	   peak	   plasmonic	   image	  
intensity	   after	   association	   phase	   and	   correlation	   of	   kinetics	   parameters	   can	   be	  
found	  in	  the	  Supporting	  Information.	  This	   information	  can	  be	  found	  free	  of	  charge	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